{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:46:53Z","timestamp":1786636013773,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0253-7613.64496","type":"journal-article","created":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T21:22:05Z","timestamp":1277068925000},"page":"112","source":"Crossref","is-referenced-by-count":5,"title":["Amisulpride induced mania"],"prefix":"10.4103","volume":"42","author":[{"given":"Ashish","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RC","family":"Jiloha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.64496-1","first-page":"180","volume-title":"Amisulpride, an Unusual \"Atypical\" antipsychotic: A Meta-Analysis of randomized controlled trials","author":"Leucht","year":"2002","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0253-7613.64496-2","first-page":"933","volume-title":"Amisulpride: A review of its use in the management of schizophrenia","author":"McKeage","year":"2004","journal-title":"CNS Drugs"},{"key":"key-10.4103\/0253-7613.64496-3","first-page":"172","volume-title":"Amisulpride-induced mania in a induced mania patient with schizophrenia","author":"Murphy","year":"2003","journal-title":"Br J Psychiatry"},{"key":"key-10.4103\/0253-7613.64496-4","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clinical Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.64496-5","first-page":"1255","volume-title":"Adverse drug reactions: Definitions, diagnosis and management","author":"Edwards","year":"2000","journal-title":"The Lancet"},{"key":"key-10.4103\/0253-7613.64496-6","first-page":"297","volume-title":"Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide","author":"Post","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"key":"key-10.4103\/0253-7613.64496-7","first-page":"1533","volume-title":"CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls","author":"Gerner","year":"1984","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0253-7613.64496-8","first-page":"19","volume-title":"An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients","author":"Carta","year":"2006","journal-title":"Clin Pract Epidemiol Ment Health"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:52:49Z","timestamp":1786632769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.64496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["64496"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.64496","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}